Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Addressing the Third Delay in Saving Mothers, Giving Life Districts in Uganda and Zambia: Ensuring Adequate and Appropriate Facility-Based Maternal and Perinatal Health Care.

Morof D, Serbanescu F, Goodwin MM, Hamer DH, Asiimwe AR, Hamomba L, Musumali M, Binzen S, Kekitiinwa A, Picho B, Kaharuza F, Namukanja PM, Murokora D, Kamara V, Dynes M, Blanton C, Nalutaaya A, Luwaga F, Schmitz MM, LaBrecque J, Conlon CM, McCarthy B, Kroelinger C, Clark T.

Glob Health Sci Pract. 2019 Mar 13;7(Suppl 1):S85-S103. doi: 10.9745/GHSP-D-18-00272. Print 2019 Mar 11.

2.

Addressing the Second Delay in Saving Mothers, Giving Life Districts in Uganda and Zambia: Reaching Appropriate Maternal Care in a Timely Manner.

Ngoma T, Asiimwe AR, Mukasa J, Binzen S, Serbanescu F, Henry EG, Hamer DH, Lori JR, Schmitz MM, Marum L, Picho B, Naggayi A, Musonda G, Conlon CM, Komakech P, Kamara V, Scott NA.

Glob Health Sci Pract. 2019 Mar 13;7(Suppl 1):S68-S84. doi: 10.9745/GHSP-D-18-00367. Print 2019 Mar 11.

3.

Addressing the First Delay in Saving Mothers, Giving Life Districts in Uganda and Zambia: Approaches and Results for Increasing Demand for Facility Delivery Services.

Serbanescu F, Goodwin MM, Binzen S, Morof D, Asiimwe AR, Kelly L, Wakefield C, Picho B, Healey J, Nalutaaya A, Hamomba L, Kamara V, Opio G, Kaharuza F, Blanton C, Luwaga F, Steffen M, Conlon CM.

Glob Health Sci Pract. 2019 Mar 13;7(Suppl 1):S48-S67. doi: 10.9745/GHSP-D-18-00343. Print 2019 Mar 11.

4.

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.

Musiime V, Cook A, Kayiwa J, Zangata D, Nansubuga C, Arach B, Kenny J, Wavamunno P, Komunyena J, Kabamba D, Asiimwe AR, Mirembe G, Abongomera G, Mulenga V, Kekitiinwa A, Kityo C, Walker SA, Klein N, Gibb DM; CHAPAS-3 trial team.

Antivir Ther. 2014;19(3):269-76. doi: 10.3851/IMP2695. Epub 2013 Oct 25.

PMID:
24717427
5.

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Tukei VJ, Murungi M, Asiimwe AR, Migisha D, Maganda A, Bakeera-Kitaka S, Kalyesubula I, Musoke P, Kekitiinwa A.

BMC Pediatr. 2013 Mar 27;13:42. doi: 10.1186/1471-2431-13-42.

6.

Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.

Kekitiinwa A, Asiimwe AR, Kasirye P, Korutaro V, Kitaka S, Maganda A, Madalon M, Graziano FM.

Pediatr Infect Dis J. 2012 Aug;31(8):e117-25. doi: 10.1097/INF.0b013e31825cb9d6.

PMID:
22581223

Supplemental Content

Loading ...
Support Center